1. Bluesky Feeds /
  2. American Society of Hematology /
  3. Hematology

This is a feed for #hematology researchers and clinicians capturing the global conversation in hematology research, clinical practice, and scientific discovery. This feed aggregates posts from hematology professionals, researchers, and institutions discussing #BloodScience!

Feed on Bluesky

Feeds Stats

  • 💙 Liked by 3 users
  • 📅 Updated 2 months ago
  • ⚙️ Provider skyfeed.me

Hematology Likes over time

Like count prediction
The feed Hematology has not gained any likes in the last month.

Feed Preview for Hematology

Cancer Therapy Advisor
@cancertherapyadv.bsky.social
about 8 hours ago
MRD is “a credible intermediate endpoint” for some patients with newly diagnosed #AML. Presented at #ASH25 by @jessetettero.bsky.social of @fralinbiomed.bsky.social. bit.ly/4j2f79h #leusm
0
0
0
Hematology Advisor
@hematologyadvisor.bsky.social
about 10 hours ago
Combining post-transplantation cyclophosphamide with sirolimus and cyclosporine appears to reduce the incidence of #cGVHD compared with sirolimus, cyclosporine, and MMF. Published in @ascopost.bsky.social Journal of Clinical Oncology. bit.ly/48VJZnn #GVHD
Post-Transplantation Cyclophosphamide May Reduce Chronic GVHD Risk Compared With MMF

bit.ly

Post-Transplantation Cyclophosphamide May Reduce Chronic GVHD Risk Compared With MMF

Combining post-transplantation cyclophosphamide with sirolimus and cyclosporine appears to reduce the incidence of cGVHD compared with sirolimus, cyclosporine, and MMF.

0
0
0
American Society of Hematology
@ash.hematology.org
about 11 hours ago
Don’t forget to claim your CME/MOC credit for attending #ASH25! ✅ Complete the evaluation survey by April 10, 2026, to claim credit and print your certificate. Claim now: ow.ly/HGGO50XKxJy #HemeSky #MedSky #Hematology #HemeOnc
0
0
1
Amyloidosis Research Consortium
@amyloidosis.bsky.social
about 11 hours ago
This holiday season, we here at ARC want to take a moment to thank our incredible community. Your dedication and compassion help us shine a light of hope for all those affected by #amyloidosis. We wish you and your loved ones a wonderful holiday season and a hopeful new year.
0
0
0
Lymphoma hub
@lymphomahub.bsky.social
about 13 hours ago
The Lymphoma Hub was pleased to speak with Alexey Danilov at #ASH25. We asked, What are the latest updates from the phase I NX-5948-301 trial of bexobrutideg in patients with R/R CLL? Watch here: loom.ly/M45g2y4 #lymsm #leusm #MedEd
0
0
0
American Society of Hematology
@ash.hematology.org
about 14 hours ago
Dr. Oyedeji’s #NIH-funded SCD study was cut midway. Such funding cuts not only disrupt patient care but also may discourage researchers, particularly those from underrepresented backgrounds. Learn more: ow.ly/aYaV50XKqQU #Fight4Hematology #ResearchSavesLives #SickleCell #HemeSky
0
1
4
ASH Clinical News
@ashclinicalnews.bsky.social
about 15 hours ago
For patients with myeloid/lymphoid #neoplasms with FGFR1 rearrangements, #pemigatinib led to high rates of complete clinical and cytogenetic responses in chronic-phase disease, at 96% and 88%, respectively, with encouraging activity in blast-phase disease: ow.ly/UKCT50XKhvX #HemeSky #OncSky
0
0
0
Kim R 🇨🇦
@kimvr.bsky.social
about 15 hours ago
When you finally let go of the past something better comes along. #recovered #anxiety #irondeficiencyanemia #anorexia #nevergiveup #AlwaysKeepFighting #fibromyalgia #mecfs
0
0
0
International Society of Geriatric Oncology (SIOG)
@siogorg.bsky.social
about 18 hours ago
Designing studies in #GeriatricOncology often requires approaches beyond standard methods. The #SIOGResearchMasterclass offers hands-on learning, small-group work, and expert guidance in a focused setting. Florida · Apr 8–10, 2026 Apply by Mar 8: loom.ly/QFO3xsk #GeriOnc
0
0
0
Lymphoma hub
@lymphomahub.bsky.social
about 19 hours ago
During our latest steering committee meeting, Gareth Gregory discussed updated results from the phase III STARGLO trial of Glofit-GemOx vs R-GemOx in patients with R/R DLBCL. Listen here: loom.ly/Mf-snvI #lymphoma #lymsm #MedEd #MedNews
0
0
0
Anaesthesia
@anaesjournal.bsky.social
about 21 hours ago
Pre-operative anaemia is an established risk factor for mortality after cardiac surgery. To what extent is this risk mediated by complications related to red blood cell transfusion? #AnSky #HemeSky #MedSky #anaemia doi.org/10.1111/anae...
0
0
2
Global MPN Scientifc Foundation
@gmpnsf.bsky.social
about 24 hours ago
From a daughter’s story to supporting the MPN community 🌿 Meet Tania, personal trainer & occupational therapist, now part of our Wellbeing Project 💪 🔗 gmpnsf.org/wellbeing #MPNsm
0
0
0
Ajay Major, MD, MBA
@majorajay.bsky.social
1 day ago
Also no difference in hours spent at infusion center between IV vs SQ formulations. Overall, these data are first & largest of patient-reported time burden with different bispecifics in FL & DLBCL, and provide concrete data to better counsel patients as part of shared decision-making. #ASH25 #lymsm
0
0
0
Ajay Major, MD, MBA
@majorajay.bsky.social
1 day ago
Significantly fewer all-cause visits with mosun in FL and glofi in DLBCL at 1.6 and 0.8 fewer visits, respectively, vs epcor. 50% reduction in hours spent on cancer-related care with mosun & glofi vs epcor (including less time recovering at home). #ASH25 #lymsm
1
0
0
Ajay Major, MD, MBA
@majorajay.bsky.social
1 day ago
Enrolled 60 patients w/ FL & 60 w/ DLBCL, all actively on BsAb therapies for >1 month. Over 1/4 were non-White, most urban/suburban, majority treated in academic centers. Majority had been on treatment for >4-6 months. #ASH25 #lymsm
1
0
0
Ajay Major, MD, MBA
@majorajay.bsky.social
1 day ago
At #ASH25, we presented our patient-reported time toxicity study in 120 pts w/ R/R FL & DLBCL on mosun, glofi & epcor. Mosun & glofi w/⬇️all-cause healthcare visits & hours spent on cancer-related care in past 30 days v epcor. More details in this #thread. #lymsm www.sciencedirect.com/sci….
1
0
1
American Society of Pediatric Hematology/Oncology
@aspho-hq.bsky.social
1 day ago
Only 3 days remain to submit your abstract! Join the discussion and showcase your #PedsHemeOnc expertise with fellow #PHODocs by presenting a paper or poster at #ASPHO2026. Learn more: aspho.org/meetings/con...
0
0
0
Cancer Therapy Advisor
@cancertherapyadv.bsky.social
1 day ago
@rahulbanerjeemd.bsky.social of @fredhutch.org discusses major advances in bispecific antibodies presented at #ASH25 for #multipleMyeloma. Read and watch more here: ➡️ bit.ly/3KMNsg0 #myeloma #mmsm
Video thumbnail
Play button
0
1
1
Soumya Rangarajan, MD, MPP
@soumya-goblue.medsky.social
1 day ago
I assume they live in #SiliconValley but do they ever stir out? There are many parts of this country with no GPS access. I remember as #medstudent going to #hemeonc preceptor #rural clinic in #Iowa - no bars on cell; planned route on paper, lonely country roads- never got lost - as a brown woman 🤯
1
0
3
Lymphoma hub
@lymphomahub.bsky.social
1 day ago
🚨 NEWS 🚨 FDA grants priority review to nivolumab + AVD for adult and pediatric patients aged ≥12 years with previously untreated Stage III or IV cHL. Read more here: loom.ly/NgQIEgM #MedNews #lymsm #lymphoma
0
0
0